Physician

Matthew A Voorsanger, MD

According to 2025 Medicare claims, Matthew Voorsanger, MD (NPI: 1073506143) practices cardiology in the Bremerton-Silverdale-Port Orchard, WA market, with the plurality of this provider's patient population coming from Kitsap, WA. This provider's primary affiliated billing organization is FRANCISCAN MEDICAL GROUP (NPI: 1366539421; TIN: 911939739) and primary practice location at 98383-7663. Voorsanger is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Sound Physicians Long Term Care Management, LLC (ACO ID: A5220), and Jefferson Accountable Care, LLC (ACO ID: A5275), participating under the MSSP model.

Voorsanger's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,452 traditional Medicare patients, billed 5,247 HCPCS/CPT codes, and received $295,607 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 4,251 prescription claims across 693 beneficiaries totaling $1,173,985 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 2 records totaling $43. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $20,406 to $295,607. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,354 to $1,173,985. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	126	263	$20,406
2016	298	787	$56,843
2017	502	1,124	$89,731
2018	781	1,719	$137,335
2019	997	2,432	$162,605
2020	881	2,019	$125,320
2021	937	2,592	$170,570
2022	1,217	4,007	$257,263
2023	1,406	4,755	$296,418
2024	1,452	5,247	$295,607

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	34	94	$1,354
2016	34	90	$4,392
2017	139	420	$22,812
2018	304	1,938	$143,961
2019	431	2,597	$250,364
2020	562	3,055	$388,928
2021	591	3,259	$490,520
2022	585	3,369	$605,039
2023	626	3,717	$770,586
2024	693	4,251	$1,173,985

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	361	362	$123
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	192	192	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	550	812	$90
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	188	584	$15
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	434	465	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	299	21,726	$417,285
Xarelto	Rivaroxaban	133	9,872	$175,927
Jardiance	Empagliflozin	57	4,218	$79,917
Repatha Sureclick	Evolocumab	42	2,881	$53,795
Entresto	Sacubitril/Valsartan	42	2,735	$49,676

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$43	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew A. Voorsanger, MD?

Tedicare shows public-source Medicare data for Matthew A. Voorsanger, MD (NPI 1073506143), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew A. Voorsanger, MD have ACO affiliation data?

Matthew A. Voorsanger, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Sound Physicians Long Term Care Management, LLC (MSSP, ACO ID A5220), and Jefferson Accountable Care, LLC (MSSP, ACO ID A5275).

What billing organization is linked to Matthew A. Voorsanger, MD?

Matthew A. Voorsanger, MD is linked to FRANCISCAN MEDICAL GROUP (billing NPI 1366539421) in the available physician profile data.

Does Matthew A. Voorsanger, MD have Open Payments data?

Matthew A. Voorsanger, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.